Medicare Enrolled
Dr. Tricia Westhoff-Pankratz, M.D.
Endocrinology · Santa Barbara, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Westhoff-Pankratz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Westhoff-Pankratz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Westhoff-Pankratz
Dr. Tricia Westhoff-Pankratz is an endocrinology specialist in Santa Barbara, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Westhoff-Pankratz performed 38,328 Medicare services across 2,068 unique beneficiaries.
Between the years covered by Open Payments, Dr. Westhoff-Pankratz received a total of $87,890 from 72 pharmaceutical and/or device companies across 1221 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Westhoff-Pankratz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in CA
$87,890 industry payments
Medicare Practice Summary
Medicare Utilization ↗38,328
Medicare services
Top 1% in CA for endocrinology
2,068
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,017 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
20,810 | $0 | $0 |
| Denosumab injection (Prolia/Xgeva) | 14,460 | $18 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,121 | $96 | $175 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
401 | $9 | $25 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
354 | $12 | $45 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
285 | $146 | $235 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
277 | $28 | $65 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
168 | $100 | $205 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
162 | $3 | $10 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
59 | $134 | $275 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
39 | $120 | $425 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
33 | $68 | $200 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
32 | $23 | $30 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
31 | $8 | $15 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
29 | $27 | $60 |
| New patient office visit, complex (60-74 min) | 25 | $189 | $335 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $43 | $120 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
20 | $139 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$87,890
Total received (2018-2024)
Avg $12,556/year across 7 years
Top 5% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
1,221
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$64,788 (73.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,343 (22.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,759 (4.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,992
2023
$15,251
2022
$26,773
2021
$2,582
2020
$4,834
2019
$12,328
2018
$21,128
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$956
Lilly USA, LLC
$516
Novo Nordisk Inc
$412
Mannkind Corporation
$399
Corcept Therapeutics
$369
Abbott Laboratories
$299
Boehringer Ingelheim Pharmaceuticals, Inc.
$242
RECORDATI_RARE_DISEASES_INC.
$203
Xeris Pharmaceuticals, Inc.
$189
AstraZeneca Pharmaceuticals LP
$143
Radius Health, Inc.
$131
Novartis Pharmaceuticals Corporation
$123
Tandem Diabetes Care, Inc.
$116
Dexcom, Inc.
$102
Astellas Pharma US Inc
$99
GENZYME CORPORATION
$96
SANOFI-AVENTIS U.S. LLC
$90
Bayer Healthcare Pharmaceuticals Inc.
$75
Insulet Corporation
$70
ABBVIE INC.
$57
Nevro Corp.
$44
Almatica Pharma LLC
$42
Neurocrine Biosciences, Inc.
$32
Inari Medical, Inc.
$29
Madrigal Pharmaceuticals
$24
Medtronic, Inc.
$23
Ascensia Diabetes Care Us Inc.
$22
BETA BIONICS, INC.
$22
Amphastar Pharmaceuticals, Inc.
$19
Chiesi USA, Inc.
$19
Tolmar, Inc.
$15
IBSA Pharma Inc.
$14
Top 3 companies account for 37.7% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$35,845
Janssen Pharmaceuticals, Inc
$11,721
SANOFI-AVENTIS U.S. LLC
$11,073
Dexcom, Inc.
$8,319
Corcept Therapeutics
$3,463
Novo Nordisk Inc
$3,359
Amgen Inc.
$2,134
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,536
Abbott Laboratories
$912
AstraZeneca Pharmaceuticals LP
$903
Mannkind Corporation
$832
Radius Health, Inc.
$565
Medtronic, Inc.
$551
MannKind Corporation
$548
Medtronic MiniMed, Inc.
$542
Bayer Healthcare Pharmaceuticals Inc.
$404
Nevro Corp.
$372
Tandem Diabetes Care, Inc.
$345
Xeris Pharmaceuticals, Inc.
$314
Insulet Corporation
$312
AbbVie Inc.
$282
Merck Sharp & Dohme Corporation
$260
RECORDATI_RARE_DISEASES_INC.
$257
Companion Medical, Inc.
$197
Bayer HealthCare Pharmaceuticals Inc.
$191
Edwards Lifesciences Corporation
$169
Alexion Pharmaceuticals, Inc.
$152
PFIZER INC.
$142
Amarin Pharma Inc.
$138
Astellas Pharma US Inc
$131
Eisai Inc.
$123
Novartis Pharmaceuticals Corporation
$123
ABBVIE INC.
$115
Acerus Pharmaceuticals Corporation
$115
GENZYME CORPORATION
$96
Esperion Therapeutics, Inc.
$89
Zealand Pharma US, Inc.
$87
BioMarin Pharmaceutical Inc.
$70
Kyowa Kirin, Inc.
$66
Ascensia Diabetes Care Us Inc.
$65
AbbVie, Inc.
$61
IBSA Pharma Inc.
$57
CeQur Corporation
$57
Ultragenyx Pharmaceutical Inc.
$53
Endogastric Solutions, Inc
$52
Currax Pharmaceuticals LLC
$44
Almatica Pharma LLC
$42
Senseonics, Incorporated
$40
Ascensia Diabetes Care US Inc.
$39
DEXCOM, INC.
$37
LifeScan, Inc.
$36
Amryt Pharma Holdings Ltd
$33
EUSA Pharma (US) LLC
$33
Neurocrine Biosciences, Inc.
$32
Inari Medical, Inc.
$29
Tolmar, Inc.
$29
Madrigal Pharmaceuticals
$24
Orexigen Therapeutics, Inc.
$24
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$23
BETA BIONICS, INC.
$22
Akcea Therapeutics, Inc.
$20
Alnylam Pharmaceuticals Inc.
$20
Horizon Therapeutics plc
$20
Amphastar Pharmaceuticals, Inc.
$19
Chiesi USA, Inc.
$19
Biohaven Pharmaceuticals, Inc.
$18
Alvogen Inc
$17
Kowa Pharmaceuticals America, Inc.
$16
Becton, Dickinson and Company
$15
Phadia US Inc.
$14
Acella Pharmaceuticals, LLC
$13
TherapeuticsMD, Inc.
$12
Top 3 companies account for 66.7% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · AFREZZA · Androgel · BAQSIMI · BD Nano · BREZTRI · BYDUREON · Belviq · CONTRAVE · CRYSVITA · CYCLOSET · CeQur Simplicity · Contour Next · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · ESOPHYX · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · Eversense · FARXIGA · FLOWTRIEVER CATHETER · FORTEO · FREESTYLE COPILOT · FREESTYLE INSULINX · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Lite system · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMALOG · HUMULIN · IMVEXXY · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKANA · ISTURISA · ImmunoCAP · InPen · JANUVIA · JARDIANCE · JATENZO · KEVEYIS · Kerendia · Korlym · Kuvan · LEQVIO · Lenvima · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYALEPT · MYCAPSSA · Minimed 670G System · Minimed 770G System · Minimed Paradigm Revel · NEXLETOL · NP Thyroid 60 · NURTEC ODT · Natesto · ONPATTRO · OT Verio Reflect "One Touch Meter and Strips" · Omnia · Omnipod · OneTouch Verio Reflect · Ozempic · PAXLOVID · PRALUENT · PROCLAIM · Prolia · RECORLEV · RESMETIROM · RYBELSUS · Repatha · Rybelsus · S · SAPIEN 3 Ultra RESILIA · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Senza · Strensiq · Sylvant · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UBRELVY · Vascepa · Veozah · Victoza · Wegovy · ZEGALOGUE · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (74%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for endocrinology in CA.
Geographic Context
Endocrinologists within 10 mi
11
Per 100K population
2.5
County median income
$95,977
Nearest hospital
SANTA BARBARA COUNTY PSYCHIATRIC HEALTH FACILITY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Westhoff-Pankratz is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with speaking/promotional industry engagement in the top 5% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Westhoff-Pankratz experienced with testosterone injection?
Based on Medicare claims data, Dr. Westhoff-Pankratz performed 20,810 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Westhoff-Pankratz receive payments from pharmaceutical companies?
Yes. Dr. Westhoff-Pankratz received a total of $87,890 from 72 companies across 1,221 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Westhoff-Pankratz's costs compare to other endocrinologists in Santa Barbara?
Dr. Westhoff-Pankratz's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Westhoff-Pankratz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Santa Barbara
Browse endocrinologists in Santa Barbara ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in CA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in CA
Which CA endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology